progressive supranuclear palsy - novel: home · early dysphagia and dysarthria . ... pseudobulbar...
TRANSCRIPT
Progressive Supranuclear Palsy
HARVARD MEDICAL SCHOOLDEPARTMENT OF NEUROLOGY
MASSACHUSETTS GENERAL HOSPITAL
HARVARD MEDICAL SCHOOLDEPARTMENT OF NEUROLOGY
MASSACHUSETTS GENERAL HOSPITAL
HARVARD MEDICAL SCHOOLDEPARTMENT OF NEUROLOGY
MASSACHUSETTS GENERAL HOSPITAL
Shirley H. Wray, M.D., Ph.D.
Professor of Neurology, Harvard Medical School
Director, Unit for Neurovisual Disorders
Massachusetts General Hospital
Criteria for Dx PSP
Gradually progressive disorder Onset at age 40 years old or later Vertical supranuclear palsy Slowing of vertical saccades Postural instability with falls in the first
year of disease onset
Supportive Criteria for Dx PSP Symmetric akinesia or rigidity Abnormal neck posture, especially
retrocollis Poor or absent response of parkinsonism
to levodopa therapy Early dysphagia and dysarthria Early onset of cognitive impairment,
including at least 2 of these: apathy, decreased verbal fluency, impaired abstract reasoning, and utilization behavior
Clinical Features of PSP
Slow vertical saccades, especially down, with a preserved range of movement, may be the first sign of the disorder; later, loss of vertical saccades and quick phases
Horizontal saccades become slow and hypometric
Disruption of steady gaze by horizontal saccadic intrusions (square-wave jerks)
Impaired smooth pursuit, vertically (reduced range) and horizontally (with catch-up saccades)
Clinical Features of PSP
Smooth eye-head tracking may be relatively preserved, especially vertically
Preservation of vestibulo-ocular reflex Horizontal disconjugacy suggesting INO Loss of convergence Ultimately, all eye movements may be lost,
but vestibular movements are the last to go
Clinical Features of PSP
Eyelid disorders: delay in lid opening, lid lag, repetitive blinking in response to flashlight stimulus (failure to habituate), blepharospasm
Tonic head deviation opposite to direction of body rotation (vestibulocollic reflex)
Inability to clap just three times (applause sign)
Leigh RJ, Zee DS. Diagnosis of Central Disorders of Ocular Motility. Chpt 12: 598-718. The Neurology of Eye Movements, Fourth Edition. Oxford University Press, NY, 2006.
Neuroimaging
Figure 1: Sagittal T2-weighted MR in another patient with PSP shows the tectal plate is markedly thinned and atrophic. Courtesy Anne Osborn, MD.
Figure 2. Single photon emission tomography (PET) scan of a patient with PSP demonstrating frontal lobe hypoperfusion.
Figure 3. PET in a patient with PSP. Showing area of hypoperfusion (blue).
Pathology
Figure 4: PSP_pale locus ceruleus Figure 5: PSP_pale substantia nigra
Pathology
Figure 6: PSP-the-globose Tangle
Pathology
Figure 7: PSP-tau-globose-tangle Figure 8: PSP-tau-tufted
Tauopathies: Clinical Diseases
Alzheimer’s disease PSP Dementia pugilistica MSA Guam ALS/PD Corticobasogangli- Pick disease onic degeneration Argyrophilic grain FTDP-17 disease Postencephalatic PD Nieman-Pick, type C Autosomal recess- SSPE ive PD
References
Freidman DI, Jankovic, J, McCrary III JA. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuro-ophthalmol. 1992 Jun; 12(2):104-109.
Growden JH, Rossor MN. The Dementias.
Blue Books of Practical Neurology. Butterworth-Heinemann 1998; vol 19.
Richardson JC, Steele J, Oszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of heterogenous system degeneration. Trans Am Neurol Assoc. 1963; 88:25-29.
Stanford PM, Halliday GM, Brooks WS, Kwok JBJ, Storey CE, Creasey H, Morris JGL, Fulham MJ, Schofield PR. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: explanation of the disease phenotype caused by tau gene mutations. Brain 2000; 123(Pt 5): 880-893.
http://www.library.med.utah.edu/NOVEL